Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity.
Methotrexate, an antirheumatic drug that may increase serum homocysteine, significantly increases mortality in patients with rheumatoid arthritis and cardiovascular comorbidity.